DOWNLOAD THE PAYER DOSSIER
Add TBS Osteo to your DXA routine to benefit from the NEW US Reimbursement codes. Plus, with TBS Osteo being seamlessly integrated to your DXA workflow, you can increase the value of your existing DXA practice and provide better patient care.
Download the payer dossier and see:
- Demonstration of the Clinical Need for TBS in assessment of fracture risk
- Evidence of Clinical Utility
- A subset of Clinical Evidence to support payer coverage
- National and International Medical Organizations with Guidelines supporting use of TBS
THE MISSING LINK TO FRACTURE PREDICTION
FACTS
30% of osteopenic patients are about the same risk of fracture as some of those who are osteoporotic, but aren’t classified or managed accordingly1
Evidence suggests that many women who sustain a fragility fracture are not appropriately diagnosed and treated for probable osteoporosis2,3,4,5
The great majority of individuals at high risk (possibly 80%), who have already had at least one osteoporosis fracture, are neither identified nor treated6
BMD alone does not satisfy the WHO definition of osteoporosis, which is described as ‘a silent systemic skeletal disease characterized by low bone mass (BMD) and a micro-architectural deterioration (TBS) of bone tissues leading to an important increase of bone fragility and increase fracture risk.’
Standard DXA procedures only provide information for half of the definition – only BMD, not structure.
BMD alone cannot identify all patients who are at risk of fracture
Over 50% of patients with osteoporotic fractures have normal or osteopenic BMD values. These patients are underdiagnosed with BMD alone1
Two patients can have the same BMD but that doesn’t mean they are at the same risk of fracture
WHY?
TBS OSTEO IS A CLINICAL ADDED VALUE FULFILLING THE WHO OSTEOPOROSIS DEFINITION
WHAT IS TBS OSTEO?
TBS Osteo is an advanced imaging software application for bone densitometers (DXA) assessing the microarchitectural deterioration of bone tissue. It computes a Trabecular Bone Score (TBS), which provides extremely useful additional clinical information as to the microarchitecture of the bone.
The combination of TBS, BMD and clinical risk factors or FRAX provides a more comprehensive overview of a patient’s bone health.
DXA + TBS = Density + Structure
3 EASY STEPS
1. DXA SCAN
2. TBS AUTOMATIC DETECTION
3. TBS ALL-IN-ONE REPORT
BENEFITS OF TBS OSTEO
Discover the clinical, financial, and operational benefits of TBS Osteo
UP YOUR DXA BUSINESS
Add TBS Osteo to your DXA routine to benefit from the NEW US Reimbursement codes.
1The Manitoba Study: Prospective study that aimed to elucidate the ability of lumbar spine TBS to predict future clinical osteoporotic fractures. Sample: 29,407 women age 50 or older at time of baseline in the Canadian province of Manitoba, mean follow-up time of 4.7 years. Hans et al. ,2011, J. Bone Miner. Res. 26
2Freedman, K.B., et al., Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am, 2000. 82-A(8): p. 1063-70.
3Siris, E.S., et al., Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment
4International Osteoporosis Foundation: Broken bones, broken lives: a roadmap to solve the fragility fracture crisis in Europe. 2018
5Shah, A., et al., Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study. Osteoporos Int, 2017. 28(1): p. 169-178
6Hernlund, E., et al., Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos, 2013. 8: p. 136.